Previous close | 21.20 |
Open | 21.00 |
Bid | 21.60 x N/A |
Ask | 21.80 x N/A |
Day's range | 21.00 - 21.60 |
52-week range | 19.70 - 25.60 |
Volume | |
Avg. volume | 1 |
Market cap | 4.793B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 27.34 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.66 (3.14%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.